Pamela Kirby

Pamela J.
Kirby currently works at Bunzl Plc, as Senior Independent Non-Executive Director from 2022, Reckitt Benckiser Ltd., as Non-Executive Director, and King's Health Partners Ltd., as Non-Executive Director.
Dr. Kirby also formerly worked at Quintiles Transnational Corp., as Chief Executive Officer from 2001 to 2003, SCYNEXIS, Inc., as Chairman from 2006 to 2015, Oxford Immunotec Ltd., as Non-Executive Chairman, Oscient Pharmaceuticals Corp., as Non-Executive Director, AstraZeneca PLC, as Regional Director, Ligand UK Ltd., as Director, F.
Hoffmann-La Roche Ltd., as Director-Global Strategic Marketing, Novo Nordisk A, as Non-Executive Director in 2011, Smith & Nephew plc, as Independent Non-Executive Director from 2012 to 2014, Hikma Pharmaceuticals Plc, as Independent Non-Executive Director from 2014 to 2022, DCC Plc, as Independent Non-Executive Director from 2013 to 2022, Informa Switzerland Ltd., as Senior Independent Non-Executive Director from 2011 to 2014, Victrex Plc, as Senior Independent Non-Executive Director from 2014 to 2020, Simmons & Simmons LLP, as Non-Executive Director from 2011 to 2013, Curalogic AS, as Non-Executive Director, Informa Plc, as Senior Independent Director, Reckitt Benckiser Group Plc, as Independent Non-Executive Director from 2015 to 2024, and Akzo Nobel NV, as Member-Supervisory Board from 2016 to 2024.
Dr. Kirby received her undergraduate degree in 1975 and doctorate degree in 1978 from the University of London.